Back | Next |
home / stock / vtvt / vtvt message board
Subject | By | Source | When |
---|---|---|---|
New SEC Filing: 8-K Material Agrmt - vTv | cjstocksup | investorshub | 06/01/2022 12:13:38 PM |
whytestocks: $VTVT News Article - vTv Therapeutics Announces Investment by and Entry into Collaborat | whytestocks | investorshangout | 06/01/2022 12:10:58 PM |
News | Awl416 | investorshub | 06/01/2022 11:12:12 AM |
vTv Therapeutics Announces Entry Into Agreements That Include | crudeoil24 | investorshub | 06/01/2022 11:07:03 AM |
Or drop big :-) | Investor2014 | investorshub | 04/23/2022 2:05:36 PM |
$VTVT | TommyBoyTrader9460 | investorshub | 02/21/2022 12:44:17 PM |
znewcar1: VTVT 19% v1,66M c.8488 f66,9M H.8715 S@.78? | znewcar1 | investorshangout | 02/18/2022 10:09:40 PM |
VTVT: This could run-up nicely today, behind substantive | Just-Keep-Trying | investorshub | 02/18/2022 3:12:26 PM |
Really not till the start of 2022....but you | Tom turtles | investorshub | 10/25/2021 2:32:17 AM |
I am surprised this has not gotten more | murocman | investorshub | 10/23/2021 3:11:30 PM |
Too cheap to ignore here ! | Tom turtles | investorshub | 10/23/2021 6:32:55 AM |
$DWAC.....craziness | Tom turtles | investorshub | 10/21/2021 8:04:20 PM |
Likely because they are woefully behind on their | murocman | investorshub | 10/21/2021 4:34:05 PM |
Well look at $ADMP......they get FDA approval and | Tom turtles | investorshub | 10/21/2021 10:31:47 AM |
P2 trials planned to initiate in 2022. I | Investor2014 | investorshub | 10/21/2021 10:12:35 AM |
Just need it to get past $3 over | Tom turtles | investorshub | 10/21/2021 9:25:25 AM |
Most of his shares were bought above $4. | Tom turtles | investorshub | 10/21/2021 9:09:12 AM |
Perelman has years ago signed an agreement with | Investor2014 | investorshub | 10/21/2021 7:53:25 AM |
It seems he owns about 80% of the | Tom turtles | investorshub | 10/21/2021 6:57:47 AM |
You like this thing Invest2014 ? Right now | Tom turtles | investorshub | 10/21/2021 4:50:37 AM |
News, Short Squeeze, Breakout and More Instantly...
vTv Therapeutics Inc. Company Name:
VTVT Stock Symbol:
NASDAQ Market:
vTv Therapeutics Inc. Website:
2024-06-26 16:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Cadisegliatin is a potential first-in-class oral liver selective glucokinase activator for T1D, which has been granted Breakthrough Therapy designation by the FDA for T1D Cadisegliatin has been dosed in over ...
CANTEX PHARMACEUTICALS ANNOUNCES FOUR ABSTRACTS TO BE PRESENTED FEATURING AZELIRAGON AT 2024 ASCO ANNUAL MEETING PR Newswire WESTON, Fla. , May 28, 2024 /PRNewswire/ -- Cantex Pharmaceuticals , Inc., a clinical stage pharmaceutical company focused on developi...